PUBLISHER: The Business Research Company | PRODUCT CODE: 1948202
PUBLISHER: The Business Research Company | PRODUCT CODE: 1948202
Single-use bioprocessing connectors are disposable components intended to join different elements of a bioprocessing system-such as tubing, bags, filters, and bioreactors-while maintaining sterile, leak-proof, and secure fluid transfer. These connectors facilitate essential processes, including media preparation, fermentation, and purification, and remove the need for cleaning or sterilization between production batches.
The primary types of single-use bioprocessing connectors include aseptic connectors and conventional connectors. Aseptic connectors are single-use devices that allow sterile fluid transfer in bioprocessing operations without introducing contamination risks. They are employed in a range of applications, including upstream bioprocessing, downstream bioprocessing, and fill-finish procedures. These connectors are used by biopharmaceutical and pharmaceutical companies, contract research organizations (CROs), contract manufacturing organizations (CMOs), as well as academic and research institutions.
Tariffs have influenced the single-use bioprocessing connectors market by affecting the cost of imported raw materials and components required for aseptic and conventional connectors. These tariffs have primarily impacted segments involving high-value automated connectors and regions like North America and Europe, which rely on imported manufacturing equipment. While the increased costs may slow adoption for some smaller manufacturers, tariffs have also encouraged local sourcing and regional production investments, which can drive innovation and supply chain resilience across the biopharmaceutical sector.
The single-use bioprocessing connectors market research report is one of a series of new reports from The Business Research Company that provides single-use bioprocessing connectors market statistics, including single-use bioprocessing connectors industry global market size, regional shares, competitors with a single-use bioprocessing connectors market share, detailed single-use bioprocessing connectors market segments, market trends and opportunities, and any further data you may need to thrive in the single-use bioprocessing connectors industry. This single-use bioprocessing connectors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The single-use bioprocessing connectors market size has grown rapidly in recent years. It will grow from $1.65 billion in 2025 to $1.96 billion in 2026 at a compound annual growth rate (CAGR) of 18.8%. The growth in the historic period can be attributed to growing demand for sterile connectors, rise of biopharmaceutical manufacturing, limited automation in upstream processes, reliance on conventional connectors, stringent regulatory compliance.
The single-use bioprocessing connectors market size is expected to see rapid growth in the next few years. It will grow to $3.92 billion in 2030 at a compound annual growth rate (CAGR) of 18.9%. The growth in the forecast period can be attributed to expansion of single-use technologies, integration of aseptic connectors in automated systems, increasing adoption in contract manufacturing, growth in biologics and cell therapy, focus on reducing cross-contamination risk. Major trends in the forecast period include adoption of disposable bioprocessing systems, focus on sterile and contamination-free fluid transfer, increasing upstream bioprocessing automation, shift toward single-use fill-finish operations, standardization of connector interfaces.
The growing demand for biosimilars is expected to drive the expansion of the single-use bioprocessing connectors market. Biosimilars are biologic medicines that closely replicate already approved biologic drugs, offering no clinically meaningful differences in terms of safety or effectiveness. This rising demand stems largely from the increasing prevalence of chronic diseases, which often require ongoing biologic therapies. Biosimilars provide a cost-effective alternative, making them more accessible for both patients and healthcare providers. Single-use bioprocessing connectors play a critical role in biosimilar production by enabling sterile, contamination-free fluid transfers. These connectors streamline manufacturing workflows, maintain product integrity, reduce batch failure risks, and lower operational costs-helping biosimilars reach the market more quickly. For example, in January 2023, Cardinal Health Inc., a healthcare company based in the US, reported that the number of FDA-approved biosimilars rose from 33 in 2022 to 40 by 2023, with 25 products available commercially. As a result, the increasing demand for biosimilars is fueling growth in the single-use bioprocessing connectors market.
Companies in the single-use bioprocessing connectors market are emphasizing the development of innovative disposable connectors to enhance process efficiency, lower contamination risks, and streamline biopharmaceutical manufacturing. These disposable connectors are single-use components designed to connect fluid transfer systems without requiring cleaning or sterilization. They offer significant benefits by reducing the risk of cross-contamination, decreasing cleaning validation efforts, and improving sterile fluid handling efficiency. For instance, in April 2023, CPC Colder Products Company, a US-based plastic components manufacturer, introduced the AseptiQuik W Series. This product features the industry's largest genderless aseptic connectors with a 1-1/2-inch flow path, enabling high-volume sterile fluid transfers. The design supports the rapid movement of hundreds of liters per minute, which enhances throughput, minimizes contamination risk, and eliminates the need for cleaning between production batches.
In October 2023, Getinge AB, a medical technology company headquartered in Sweden, acquired High Purity New England Inc. for $120 million. This strategic move aims to bolster Getinge's position in the rapidly expanding bioprocessing sector by incorporating High Purity New England's range of single-use solutions into its portfolio. These solutions support the development and manufacture of advanced therapies, including monoclonal antibodies, vaccines, and cell and gene therapies. High Purity New England Inc., based in the US, specializes in bioprocessing technologies such as connectors, pumps, sensors, and custom assemblies used throughout drug development and manufacturing.
Major companies operating in the single-use bioprocessing connectors market are Compagnie de Saint Gobain S A, Thermo Fisher Scientific Inc, Danaher Corporation, Merck KGaA, Sartorius AG, Repligen Corporation, Pall Corporation, Nordson Corporation, Watson Marlow Limited, Colder Products Company, Shanghai LePure Biotech Co Ltd, Qosina Corp, SaniSure GmbH, Ami Polymer Private Limited, Foxx Life Sciences LLC, Bio Link LLC, Liquidyne Process Technologies Inc, PharSol Technology Solutions Private Limited, BioPulse Solutions Inc, CPC Biopharma Connectors, AdvantaPure, Teknor Apex Healthcare
North America was the largest region in the single-use bioprocessing connectors market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-use bioprocessing connectors market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the single-use bioprocessing connectors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The single-use bioprocessing connectors market consists of sales of sterile quick connectors, push-to-connect fittings, quick connects or disconnects, tube welders and sealers, and sanitary clamps and fittings. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Single-Use Bioprocessing Connectors Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses single-use bioprocessing connectors market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for single-use bioprocessing connectors ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The single-use bioprocessing connectors market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.